Biomednewsbreaks - Quantum Biopharma Ltd. (NASDAQ: QNTM) Reports Positive Clinical Trial Results For Unbuzzdtm
Quantum BioPharma (NASDAQ: QNTM) announced the successful completion of a clinical trial demonstrating that its dietary supplement, unbuzzdTM, signi ...
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
Hangover Relief: Participants in this study noted a statistically significant reduction in hangover symptoms. This included reduced cognitive and physical impairment, and reduced headache compared to ...
Quantum Biopharma Announces the Success of unbuzzd Clinical Trial
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated ...
Tesla Q4: Cortex Supports Its Autonomous Driving Technology
Tesla’s growth in AI, energy storage, and robotics supports a $460 target price. Learn why TSLA stock is a Strong Buy despite ...
Dow Jumps Over 100 Points; Tesla Earnings Miss Views
European shares were higher today. The eurozone's STOXX 600 rose 0.6%, Germany's DAX 40 gained 0.2% and France's CAC 40 ...
Investing6d
Why Tesla is up after mixed results? Musk 'never sounded so bullish' says analyst
Tesla shares are up around 2.5% premarket despite reporting mixed Q4 results, as CEO Elon Musk struck an exceptionally ...
Tesla targets unsupervised FSD launch in Austin by June 2025 while projecting pivotal growth across AI and energy
Musk announced that unsupervised Full Self Driving (FSD) would launch as a paid service in Austin by June 2025, with plans to expand across the U.S. This includes Tesla's internal fleet already ...